An Evidence-Based Update on Nonsteroidal Anti-Inflammatory Drugs

被引:395
作者
Ong, C. K. S. [1 ]
Lirk, P. [2 ]
Tan, C. H. [3 ]
Seymour, R. A. [4 ]
机构
[1] Natl Univ Singapore, Fac Dent, Dept Oral & Maxillofacial Surg, Singapore, Singapore
[2] Med Univ Innsbruck, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria
[3] Natl Univ Singapore, Fac Med, Dept Pharmacol, Singapore, Singapore
[4] Newcastle Univ, Sch Dent Sci, Dept Dent Pharmacol, Newcastle Upon Tyne, Tyne & Wear, England
关键词
Analgesics; COX-2 specific inhibitors; NSAIDs; Pain;
D O I
10.3121/cmr.2007.698
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nonsteroidal anti-inflammatory drugs (NSAIDs), including both traditional nonselective NSAIDs and the selective cyclooxygenase (COX)-2 inhibitors, are widely used for their anti-inflammatory and analgesic effects. NSAIDs are a necessary choice in pain management because of the integrated role of the COX pathway in the generation of inflammation and in the biochemical recognition of pain. This group of drugs has recently come under scrutiny because of recent focus in the literature on the various adverse effects that can occur when applying NSAIDs. This review will provide an educational update on the current evidence of the efficacy and adverse effects of NSAIDs. It aims to answer the following questions: (1) are there clinically important differences in the efficacy and safety between the different NSAIDs, (2) if there are differences, which are the ones that are more effective and associated with fewer adverse effects, and (3) which are the effective therapeutic approaches that could reduce the adverse effects of NSAIDs. Finally, an algorithm is proposed which delineates a general decision-making tree to select the most appropriate analgesic for an individual patient based on the evidence reviewed.
引用
收藏
页码:17 / 32
页数:16
相关论文
共 111 条
  • [11] Connolly Thomas P, 2003, Clin Med Res, V1, P105
  • [12] THE NUMBER NEEDED TO TREAT - A CLINICALLY USEFUL MEASURE OF TREATMENT EFFECT
    COOK, RJ
    SACKETT, DL
    [J]. BRITISH MEDICAL JOURNAL, 1995, 310 (6977) : 452 - 454
  • [13] COOPER SA, 1994, CLIN PHARMACOL THER, V55, P126
  • [14] Cooper SA, 1991, ADV PAIN RES THER, P117
  • [15] Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers
    Cryer, B
    Berlin, RG
    Cooper, SA
    Hsu, C
    Wason, S
    [J]. CLINICAL THERAPEUTICS, 2005, 27 (02) : 185 - 191
  • [16] SAFETY PROFILE OF OVER-THE-COUNTER NAPROXEN SODIUM
    DEARMOND, B
    FRANCISCO, CA
    LIN, JS
    HUANG, FY
    HALLADAY, S
    BARTIZEK, RD
    SKARE, KL
    [J]. CLINICAL THERAPEUTICS, 1995, 17 (04) : 587 - 601
  • [17] Cyclooxygenase in biology and disease
    Dubois, RN
    Abramson, SB
    Crofford, L
    Gupta, RA
    Simon, LS
    Van De Putte, LBA
    Lipsky, PE
    [J]. FASEB JOURNAL, 1998, 12 (12) : 1063 - 1073
  • [18] Guidelines for the appropriate use of non-steroidal anti-inflammatory drugs, cyclo-oxygenase-2-specific inhibitors and proton pump inhibitors in patients requiring chronic anti-inflammatory therapy
    Dubois, RW
    Melmed, GY
    Henning, JM
    Laine, L
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (02) : 197 - 208
  • [19] Individual patient meta-analysis of single-dose rofecoxib in postoperative pain
    Jayne E Edwards
    R Andrew Moore
    Henry J McQuay
    [J]. BMC Anesthesiology, 4 (1)
  • [20] Efficacy and safety of valdecoxib for treatment of osteoarthritis and rheumatoid arthritis: systematic review of randomised controlled trials
    Edwards, JE
    McQuay, HJ
    Moore, RA
    [J]. PAIN, 2004, 111 (03) : 286 - 296